EPO Patents = 2

Forward Citations = 5

Loading Chart...

12 inventors (with patents filed for the assignee):

Dorothee Von Laer (4 out of 4 patents)

Tsanan Heimann (3 out of 3 patents)

Guido Wollmann (2 out of 7 patents)

4. Tobias Friederike Nolden (2 out of 3 patents)

5. Patrik Erlmann (2 out of 4 patents)

6. Klaus Erb (1 out of 7 patents)

7. Philipp Mueller (1 out of 3 patents)

8. John Edward Park (1 out of 19 patents)

9. Tobias Nolden (1 out of 1 patent)

10. Janine Kimpel (1 out of 1 patent)

11. Zoltan Banki (1 out of 1 patent)

12. Bart Spiesschaert (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12674143 - VSV Rescue (2026-07-07),

2. 12522844 - VSV CHIMERIC VECTORS (2026-01-13),

3. 11707495 - Recombinant rhabdovirus encoding for CCL21 (2023-07-25),

4. 10265357 - Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors (2019-04-23),

5. 9963718 - LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors (2018-05-08),

6. 9650649 - LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors (2017-05-16),

Viratherapeutics Gmbh is a biotechnology company focused on developing innovative gene therapy solutions for rare genetic diseases. With a team of experienced scientists and researchers, Viratherapeutics is dedicated to advancing gene therapy technologies to provide hope for patients with unmet medical needs. Visit our website to learn more about our mission and pipeline of gene therapy programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

6 Patents

#11 in Innsbruck

#459 in Austria

Innsbruck, Austria

Viratherapeutics Gmbh